# Oxytocin i.m./i.v. Versus Carbetocin i.v. in Elective Cesarean Sections

> **NCT03651882** · PHASE4 · COMPLETED · sponsor: **University of Zurich** · enrollment: 550 (actual)

## Conditions studied

- Postpartum Hemorrhage

## Interventions

- **DRUG:** Oxytocin
- **DRUG:** Carbetocin

## Key facts

- **NCT ID:** NCT03651882
- **Lead sponsor:** University of Zurich
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-08-07
- **Primary completion:** 2022-01-10
- **Final completion:** 2022-01-10
- **Target enrollment:** 550 (ACTUAL)
- **Last updated:** 2023-05-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03651882

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03651882, "Oxytocin i.m./i.v. Versus Carbetocin i.v. in Elective Cesarean Sections". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT03651882. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*